DarioHealth Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	21.19	22.36	27.04	27.66	20.51	7.58
Revenue Growth (YoY)	-24.41%	-17.31%	-2.23%	34.82%	170.76%	0.22%
Cost of Revenue	9.21	9.69	13.77	18	16.55	5.06
Gross Profit	11.98	12.67	13.27	9.66	3.96	2.51
Selling, General & Admin	34.47	35.53	46.83	46.82	63.24	27.98
Research & Development	12.07	13.79	24.18	19.65	17.22	4.43
Total Operating Expenses	46.54	49.32	71.01	66.47	80.46	32.42
Operating Income	-34.56	-36.66	-57.74	-56.81	-76.49	-29.9
Total Non-Operating Income (Expense)	-6.04	-4.95	13.15	-5.38	-0.24	0.46
Pretax Income	-40.6	-41.61	-44.6	-62.19	-76.73	-29.45
Provision for Income Taxes	0.14	0.11	-1.85	0	0.03	-
Net Income	-40.74	-41.71	-42.75	-62.19	-76.76	-29.45
Net Income Attributable to Preferred Dividends	15.18	20.02	-1.77	1.64	2.01	3.66
Net Income to Common	-55.92	-61.74	-40.98	-63.84	-78.77	-33.1
Shares Outstanding (Basic)	5	4	2	1	1	0
Shares Outstanding (Diluted)	5	4	2	1	1	0
Shares Change (YoY)	94.80%	62.44%	107.49%	42.45%	178.23%	163.15%
EPS (Basic)	-8.88	-10.12	-12.27	-50.80	-81.40	-80.20
EPS (Diluted)	-8.88	-10.12	-12.27	-50.80	-81.40	-80.20
Free Cash Flow	-25.44	-26.08	-38.7	-48.29	-50.67	-17.85
Free Cash Flow Per Share	-5.06	-6.55	-15.78	-40.86	-61.08	-59.88
Gross Margin	56.55%	56.64%	49.06%	34.91%	19.32%	33.17%
Operating Margin	-163.06%	-163.94%	-213.55%	-205.42%	-372.90%	-394.71%
Profit Margin	-192.23%	-186.56%	-158.09%	-224.88%	-374.21%	-388.66%
FCF Margin	-120.03%	-116.66%	-143.12%	-174.60%	-247.01%	-235.67%
EBITDA	-32.15	-33.52	-50.32	-52.09	-72.04	-29.71
EBITDA Margin	-151.71%	-149.90%	-186.08%	-188.36%	-351.18%	-392.20%
EBIT	-34.56	-36.66	-57.74	-56.81	-76.49	-29.9
EBIT Margin	-163.06%	-163.94%	-213.55%	-205.42%	-372.90%	-394.71%
Effective Tax Rate	-0.34%	-0.25%	4.15%	-0.01%	-0.04%	0.00%

SEC Filings: 10-K · 10-Q